Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Advanced and Targeted Drug Delivery market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.5% during the forecast period.
This report presents the market size and development trends by detailing the Advanced and Targeted Drug Delivery market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Advanced and Targeted Drug Delivery market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Advanced and Targeted Drug Delivery industry and will help you to build a panoramic view of the industrial development.
Advanced and Targeted Drug Delivery Market, By Type:
Liposomes
Microspheres
Nanoparticles
Emulsion
Advanced and Targeted Drug Delivery Market, By Application:
Clinic
Hospital
Others
Some of the leading players are as follows:
Nano Precision Medical Inc
Abbott Laboratories
Presage Biosciences Inc
Roche Holding AG
Novartis Pharmaceuticals Corp
Quark Pharmaceuticals Inc
Savara Inc
Rexahn Pharmaceuticals Inc
Aciont Inc
Aileron Therapeutics Inc
Acrux
3M Company
Ablynx NV
Oxford Biomedica
Replicor Inc
PharmaIN Corp
RegeneRx Biopharmaceuticals Inc
Agilis Biotherapeutics LLC
PolyMicrospheres
Pulmatrix Inc
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Advanced and Targeted Drug Delivery Market: Technology Type Analysis
-
4.1 Advanced and Targeted Drug Delivery Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Advanced and Targeted Drug Delivery Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Liposomes
4.3.2 Microspheres
4.3.3 Nanoparticles
4.3.4 Emulsion
5 Advanced and Targeted Drug Delivery Market: Product Analysis
-
5.1 Advanced and Targeted Drug Delivery Product Market Share Analysis, 2018 & 2026
-
5.2 Advanced and Targeted Drug Delivery Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Advanced and Targeted Drug Delivery Market: Application Analysis
-
6.1 Advanced and Targeted Drug Delivery Application Market Share Analysis, 2018 & 2026
-
6.2 Advanced and Targeted Drug Delivery Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Clinic
6.3.2 Hospital
6.3.3 Others
7 Advanced and Targeted Drug Delivery Market: Regional Analysis
-
7.1 Advanced and Targeted Drug Delivery Regional Market Share Analysis, 2018 & 2026
-
7.2 Advanced and Targeted Drug Delivery Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Nano Precision Medical Inc
9.1.1 Nano Precision Medical Inc Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Abbott Laboratories
9.2.1 Abbott Laboratories Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Presage Biosciences Inc
9.3.1 Presage Biosciences Inc Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Roche Holding AG
9.4.1 Roche Holding AG Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Novartis Pharmaceuticals Corp
9.5.1 Novartis Pharmaceuticals Corp Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Quark Pharmaceuticals Inc
9.6.1 Quark Pharmaceuticals Inc Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Savara Inc
9.7.1 Savara Inc Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Rexahn Pharmaceuticals Inc
9.8.1 Rexahn Pharmaceuticals Inc Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Aciont Inc
9.9.1 Aciont Inc Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Aileron Therapeutics Inc
9.10.1 Aileron Therapeutics Inc Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Acrux
9.11.1 Acrux Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 3M Company
9.12.1 3M Company Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Ablynx NV
9.13.1 Ablynx NV Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Oxford Biomedica
9.14.1 Oxford Biomedica Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Replicor Inc
9.15.1 Replicor Inc Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 PharmaIN Corp
9.16.1 PharmaIN Corp Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
9.17 RegeneRx Biopharmaceuticals Inc
9.17.1 RegeneRx Biopharmaceuticals Inc Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis
9.18 Agilis Biotherapeutics LLC
9.18.1 Agilis Biotherapeutics LLC Company overview
9.18.2 Financial performance
9.18.3 Product benchmarking
9.18.4 Strategic initiatives
9.18.5 SWOT analysis
9.19 PolyMicrospheres
9.19.1 PolyMicrospheres Company overview
9.19.2 Financial performance
9.19.3 Product benchmarking
9.19.4 Strategic initiatives
9.19.5 SWOT analysis
9.20 Pulmatrix Inc
9.20.1 Pulmatrix Inc Company overview
9.20.2 Financial performance
9.20.3 Product benchmarking
9.20.4 Strategic initiatives
9.20.5 SWOT analysis
The List of Tables and Figures (Totals 85 Figures and 126 Tables)
Figure Liposomes Advanced and Targeted Drug Delivery market, 2015 - 2026 (USD Million)
Figure Microspheres Advanced and Targeted Drug Delivery market, 2015 - 2026 (USD Million)
Figure Nanoparticles Advanced and Targeted Drug Delivery market, 2015 - 2026 (USD Million)
Figure Emulsion Advanced and Targeted Drug Delivery market, 2015 - 2026 (USD Million)
Figure Clinic market, 2015 - 2026 (USD Million)
Figure Hospital market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Advanced and Targeted Drug Delivery market, by country, 2015 - 2026 (USD Million)
-
Table North America Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table North America Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table North America Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Canada Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Canada Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Europe Advanced and Targeted Drug Delivery market, by country, 2015 - 2026 (USD Million)
-
Table Europe Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Europe Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Europe Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Germany Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Germany Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table France Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table France Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Italy Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Italy Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Spain Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Spain Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Advanced and Targeted Drug Delivery market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table China Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table China Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Japan Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Japan Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table India Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table India Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Advanced and Targeted Drug Delivery market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table MEA Advanced and Targeted Drug Delivery market, by country, 2015 - 2026 (USD Million)
-
Table MEA Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table MEA Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table MEA Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Advanced and Targeted Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Advanced and Targeted Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Advanced and Targeted Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Nano Precision Medical Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Presage Biosciences Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Roche Holding AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Pharmaceuticals Corp Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Quark Pharmaceuticals Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Savara Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Rexahn Pharmaceuticals Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aciont Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aileron Therapeutics Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Acrux Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table 3M Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Ablynx NV Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Oxford Biomedica Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Replicor Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table PharmaIN Corp Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table RegeneRx Biopharmaceuticals Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Agilis Biotherapeutics LLC Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table PolyMicrospheres Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pulmatrix Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
